FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090861623> ?p ?o ?g. }

• W2090861623 endingPage "189" @default.
• W2090861623 startingPage "180" @default.
• W2090861623 abstract "<i>Background/Aims:</i> Alzheimer disease (AD) is a complex and genetically heterogeneous disorder, and certain genes such as PS2 and APOE4 contribute to the development of AD. Due to its heterogeneity, AD-predisposing genes could vary in different populations. Moreover, not all AD patients will respond to the same therapy. We specifically investigated the effect ofrivastigmine (Exelon) on PS2 and APOE genes in Iranian AD patients. <i>Methods:</i> A total of 100 AD patients, 67 patients with sporadic AD (SAD) and 33 patients with familial AD (FAD), receiving rivastigmine therapy and 100 healthy controls were studied.PCR-RFLP was used for genotyping of PS2 and APOE. <i>Results:</i> We found a positive association between the PS2 –A allele and SAD patients (p^c = 0.01), and the PS2 +A/–A genotype was significantly more frequent in SAD than FAD patients (p^c = 0.009). The APOE4 allele was associated with total AD, SAD and FAD (p^c = 0.000002). Patients with the PS2 +A/–A genotype and bigenic genotypes of +A/–A·&#917;3/&#917;3 and +A/–A·&#917;3/&#917;4 were the best responders to Exelon therapy, and those with the PS2 +A/+A and APOE &#917;3/&#917;4 genotypes were the worst responders. <i>Conclusion:</i> Our findings suggest that the PS2 and APOE4 alleles and genotypes affect both AD risk and response to rivastigmine therapy." @default.
• W2090861623 created "2016-06-24" @default.
• W2090861623 creator A5001832015 @default.
• W2090861623 creator A5007703611 @default.
• W2090861623 creator A5045551927 @default.
• W2090861623 creator A5051203656 @default.
• W2090861623 creator A5067509760 @default.
• W2090861623 creator A5071757633 @default.
• W2090861623 creator A5091887991 @default.
• W2090861623 date "2011-06-29" @default.
• W2090861623 modified "2023-09-26" @default.
• W2090861623 title "Pharmacogenetic Study on the Effect of Rivastigmine on PS2 and APOE Genes in Iranian Alzheimer Patients" @default.
• W2090861623 cites W1968551454 @default.
• W2090861623 cites W1994184185 @default.
• W2090861623 cites W1999631936 @default.
• W2090861623 cites W2006136956 @default.
• W2090861623 cites W2018683649 @default.
• W2090861623 cites W2030751659 @default.
• W2090861623 cites W2031389661 @default.
• W2090861623 cites W2036362108 @default.
• W2090861623 cites W2043209737 @default.
• W2090861623 cites W2046209489 @default.
• W2090861623 cites W2052261143 @default.
• W2090861623 cites W2052828385 @default.
• W2090861623 cites W2058116753 @default.
• W2090861623 cites W2068166353 @default.
• W2090861623 cites W2078631745 @default.
• W2090861623 cites W2090271811 @default.
• W2090861623 cites W2091098404 @default.
• W2090861623 cites W2101077392 @default.
• W2090861623 cites W2102952062 @default.
• W2090861623 cites W2116548644 @default.
• W2090861623 cites W2117180000 @default.
• W2090861623 cites W2118094114 @default.
• W2090861623 cites W2140334576 @default.
• W2090861623 cites W2156220037 @default.
• W2090861623 cites W2162210551 @default.
• W2090861623 cites W2232562264 @default.
• W2090861623 cites W2319641678 @default.
• W2090861623 cites W2326549419 @default.
• W2090861623 cites W24086560 @default.
• W2090861623 cites W36571120 @default.
• W2090861623 cites W6632420 @default.
• W2090861623 cites W1997742019 @default.
• W2090861623 cites W2118267556 @default.
• W2090861623 doi "https://doi.org/10.1159/000329514" @default.
• W2090861623 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3199882" @default.
• W2090861623 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22163243" @default.
• W2090861623 hasPublicationYear "2011" @default.
• W2090861623 type Work @default.
• W2090861623 sameAs 2090861623 @default.
• W2090861623 citedByCount "10" @default.
• W2090861623 countsByYear W20908616232013 @default.
• W2090861623 countsByYear W20908616232015 @default.
• W2090861623 countsByYear W20908616232016 @default.
• W2090861623 countsByYear W20908616232017 @default.
• W2090861623 countsByYear W20908616232018 @default.
• W2090861623 countsByYear W20908616232019 @default.
• W2090861623 countsByYear W20908616232020 @default.
• W2090861623 countsByYear W20908616232021 @default.
• W2090861623 crossrefType "journal-article" @default.
• W2090861623 hasAuthorship W2090861623A5001832015 @default.
• W2090861623 hasAuthorship W2090861623A5007703611 @default.
• W2090861623 hasAuthorship W2090861623A5045551927 @default.
• W2090861623 hasAuthorship W2090861623A5051203656 @default.
• W2090861623 hasAuthorship W2090861623A5067509760 @default.
• W2090861623 hasAuthorship W2090861623A5071757633 @default.
• W2090861623 hasAuthorship W2090861623A5091887991 @default.
• W2090861623 hasBestOaLocation W20908616231 @default.
• W2090861623 hasConcept C104317684 @default.
• W2090861623 hasConcept C126322002 @default.
• W2090861623 hasConcept C134018914 @default.
• W2090861623 hasConcept C135763542 @default.
• W2090861623 hasConcept C180754005 @default.
• W2090861623 hasConcept C2776332859 @default.
• W2090861623 hasConcept C2779134260 @default.
• W2090861623 hasConcept C2779483572 @default.
• W2090861623 hasConcept C2780904820 @default.
• W2090861623 hasConcept C31467283 @default.
• W2090861623 hasConcept C502032728 @default.
• W2090861623 hasConcept C54355233 @default.
• W2090861623 hasConcept C55775858 @default.
• W2090861623 hasConcept C57089818 @default.
• W2090861623 hasConcept C71924100 @default.
• W2090861623 hasConcept C86803240 @default.
• W2090861623 hasConceptScore W2090861623C104317684 @default.
• W2090861623 hasConceptScore W2090861623C126322002 @default.
• W2090861623 hasConceptScore W2090861623C134018914 @default.
• W2090861623 hasConceptScore W2090861623C135763542 @default.
• W2090861623 hasConceptScore W2090861623C180754005 @default.
• W2090861623 hasConceptScore W2090861623C2776332859 @default.
• W2090861623 hasConceptScore W2090861623C2779134260 @default.
• W2090861623 hasConceptScore W2090861623C2779483572 @default.
• W2090861623 hasConceptScore W2090861623C2780904820 @default.
• W2090861623 hasConceptScore W2090861623C31467283 @default.
• W2090861623 hasConceptScore W2090861623C502032728 @default.
• W2090861623 hasConceptScore W2090861623C54355233 @default.
• W2090861623 hasConceptScore W2090861623C55775858 @default.

• next